10–14 Nov 2025
Office of Grants and Research
Africa/Accra timezone

PHYTOCHEMICAL COMPOSITION OF MEDICINAL PLANTS USED IN THE TREATMENT OF INFERTILITY IN KUMASI

Not scheduled
45m
Office of Grants and Research

Office of Grants and Research

Poster Presentation Health Systems, Basic sciences, Biomedical Advances, pharmaceutical Sciences and Human Wellbeing

Speaker

Stephanie Donkor (KNUST-KCCR)

Description

Infertility, defined as the inability to conceive after one year of unprotected intercourse, is a growing concern in Africa, where reliance on traditional medicine remains high. This study asked: How do medicinal plants used by Traditional Medicine Practitioners (TMPs) in Kumasi contribute to infertility management through their phytochemical composition?

Objectives: To document the prevalence and distribution of TMPs managing infertility in Kumasi, identify the medicinal plant preparations they use, and evaluate their phytochemical constituents.

Methodology: A survey was conducted among 50 TMPs across Kumasi. Medicinal plant products (n=68) were categorized as concoctions, raw herbs, and finished products. Fifteen representative samples were analyzed for phytochemicals including alkaloids, tannins, saponins, flavonoids, coumarins, and steroids using standard assays.

Key findings: Forty-four TMPs addressed infertility, with equal gender distribution. Herbal shop attendants (29.5%) formed the largest group, followed by herbalists and herb sellers (25% each). Subin recorded the highest number of practitioners (20.5%). Phytochemical analysis revealed high prevalence of alkaloids (93.3%), tannins (93.3%), and saponins (86.7%); moderate flavonoids (53.3%); and low coumarins (33.3%) and steroids (20%). The low presence of steroids aligns with their reported association with infertility.

Implications: The results highlight the prominence of traditional medicine in infertility care in Kumasi, with bioactive compounds that may underpin therapeutic efficacy. Findings provide a foundation for future pharmacological studies to validate safety, standardization, and integration into reproductive healthcare.

Subtheme: Health Systems, Basic Sciences, Biomedical Advances, Pharmaceutical Sciences and Human Wellbeing
Preferred presentation: Oral

Primary authors

Presentation materials

There are no materials yet.